Erk phosphorylation predicts synergism between gemcitabine and EGFR inhibitor AG1478

被引：0
|
作者：
Peter, Luk P.
Links, Matthew J.
Galettis, Peter
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-B77
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B77
引用
收藏
页数：3
相关论文
共 49 条
  • [1] ERK phosphorylation predicts synergism between gemcitabine and the epidermal growth factor receptor inhibitor AG1478
    Luk, Peter P.
    Galettis, Peter
    Links, Matthew
    LUNG CANCER, 2011, 73 (03) : 274 - 282
  • [2] EGFR inhibitor, AG1478, inhibits inflammatory infiltration and angiogenesis in mice with diabetic retinopathy
    Ju, Xin
    Yang, Xi
    Yan, Tao
    Chen, Huaicheng
    Song, Zongming
    Zhang, Zongduan
    Wu, Wencan
    Wang, Yi
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46 (01): : 75 - 85
  • [3] Combination of the EGFR Tyrosine Kinase Inhibitor AG1478 and 5-FU: No Synergistic Effect on EGFR Phosphorylation, Cell Proliferation and Apoptosis Induction
    Yagublu, Vugar
    Ahmadova, Zhala
    Hajiyeva, Yegana
    Hafner, Mathias
    Keesei, Michael
    ANTICANCER RESEARCH, 2013, 33 (09) : 3753 - 3758
  • [4] Photodynamic targeting of EGFR does not predict the treatment outcome in combination with the EGFR tyrosine kinase inhibitor Tyrphostin AG1478
    Weyergang, Anette
    Kaalhus, Olav
    Berg, Kristian
    PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2008, 7 (09) : 1032 - 1040
  • [5] Photodynamic targeting of EGFR does not predict the treatment outcome in combination with the EGFR tyrosine kinase inhibitor Tyrphostin AG1478
    Anette Weyergang
    Olav Kaalhus
    Kristian Berg
    Photochemical & Photobiological Sciences, 2008, 7 : 1032 - 1040
  • [6] Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478
    Shi, Zhi
    Tiwari, Amit K.
    Shukla, Suneet
    Robey, Robert W.
    Kim, In-Wha
    Parmar, Smitaben
    Bates, Susan E.
    Si, Qiu-Sheng
    Goldblatt, Curtis S.
    Abraham, Ioana
    Fu, Li-Wu
    Ambudkar, Suresh V.
    Chen, Zhe-Sheng
    BIOCHEMICAL PHARMACOLOGY, 2009, 77 (05) : 781 - 793
  • [7] EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells
    Zhu, XF
    Liu, ZC
    Xie, BF
    Li, ZM
    Feng, GK
    Yang, DJ
    Zeng, YX
    CANCER LETTERS, 2001, 169 (01) : 27 - 32
  • [8] AG1478 sensitive tyrosine kinase and calcium are involved in oxytocin-stimulated ERK1/2 phosphorylation.
    Zhong, M
    Yang, M
    Sanborn, BM
    BIOLOGY OF REPRODUCTION, 2002, 66 : 191 - 191
  • [9] The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth
    Shushan, A
    Rojansky, N
    Laufer, N
    Klein, BY
    Shlomai, Z
    Levitzki, R
    Hartzstark, Z
    Ben-Bassat, H
    HUMAN REPRODUCTION, 2004, 19 (09) : 1957 - 1967
  • [10] The Effects of the Tyrosine Kinase Inhibitor AG1478 in a Repeated Allergen Challenge Model of Asthma
    Siddiqui, S.
    Jo, T.
    Tsuchiya, K.
    Martin, J. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
12345